Top Analytics Companies in NYC, NY (388)

Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.

Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.

Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.

Strong Revenue Growth: Revenue scale is signaled by surpassing $500M in annual recurring revenue in July 2023, creating a high base for subsequent expansion. Company communications frame later moves as building on this milestone.

Market Expansion: Recent acquisitions—Spatial Business Systems, PDS Energy’s exchange platforms, and TGS’s A2D well log library—extend reach into utilities engineering, operational exchanges, and subsurface data. Solutions marketed across upstream, midstream, power and renewables point to a broadening footprint.

Investor Backing & Capital Strength: Blackstone agreed in August 2025 to acquire Enverus in a deal reported at $6.5B+ and later referenced deploying capital into the company in 1Q26. This indicates substantial resources and conviction to support further scaling.

Investor Backing & Capital Strength: Advent International agreed on August 25, 2025 to acquire PatientPoint, with reporting at more than $1.4B, providing external validation and resources to accelerate expansion. This backing is positioned to support network growth and product innovation.

Product Line Growth: In March 2026 PatientPoint launched programmatic buying (Health Audiences) and a Consumer Health Network aimed at CPG/OTC brands, expanding how advertisers can buy and who the company serves. These additions broaden monetization beyond traditional life‑sciences sponsors.

Strong Market Position & Advantage: PatientPoint reports a nationwide footprint in 30,000+ physician offices and 125,000 providers, and in April 2026 received expanded Media Rating Council accreditation across its full digital screen network. This scale and third‑party validation bolster credibility for national buys.

Strong Revenue Growth: Company communications describe ARR more than tripling in 2025, marking its strongest year to date. These disclosures point to clear top‑line momentum into 2026.

Product Line Growth: Announcements highlight expanded AI functionality for healthcare in June 2026 alongside ongoing platform updates. This indicates continued investment in new capabilities and vertical depth.

Strong Hiring & Retention: Multiple senior appointments in mid‑2026, including an EVP of Technology & Operations and additional leadership roles, suggest active scaling of the executive and technical bench. References to broader team expansion reinforce organizational build‑out.

Strong Revenue Growth: Recent disclosures point to record annual and early‑year trading results in 2025–2026, signaling sustained top‑line momentum. Company communications also highlight elevated platform activity in options and expanded client analytics, reinforcing growth.

Market Expansion: A new Amsterdam office and recent build‑outs in Tokyo and Sydney indicate active geographic scaling across Europe and Asia‑Pacific. Increased global hiring across trading, engineering, and research supports deeper regional coverage and client reach.

Strong Market Position & Advantage: Materials emphasize a leading role in U.S. equities and retail order flow alongside prominent standings in U.S. Treasuries and investment‑grade credit. Record retail options activity and investment in high‑touch coverage integrated with electronic scale suggest durable competitive advantages.

Strong Revenue Growth: Revenue is rising at strong double-digit rates year over year across 2025 and into mid-2026, with management increasing its outlook for 2026. Broad-based increases in originations and receivables support the top-line trajectory.

Profitability: Net income, EPS, and adjusted EBITDA are up meaningfully, and margins improved alongside stable-to-better credit metrics. This points to growth converting into stronger earnings rather than only volume expansion.

Resilient & Sustainable Growth: Multiple consecutive quarters of elevated originations and EPS growth, on top of a larger 2025 base, indicate durable momentum. Management highlights strong credit performance as a foundation for continuing expansion.

Strong Revenue Growth: A January 29, 2026 announcement states revenue grew nearly sevenfold over the prior 12 months, describing 2025 as a breakout year. This acceleration aligns with production deployments across healthcare, defense, energy, supply chain, and financial services.

Strategic Partnerships: Northslope is identified as Palantir’s first and only “Vanguard: Elite” partner and subsequently launched a Gemini Enterprise practice with Google Cloud. These moves signal strong ecosystem traction and channel leverage for enterprise AI deployments.

Market Expansion: The company opened a permanent office in Abu Dhabi in June 2026 and maintains hubs in New York, London, and Denver. Establishing a local team to serve regional demand indicates an expanding geographic footprint.

Strong Market Position & Advantage: Independent market-share analysis places Celonis at the front of its category while the market itself expands. This positioning suggests the company is capturing growth in a segment it leads.

Future-Ready Strategy: External recognition for long-term growth potential signals confidence in Celonis’s strategy, innovation, and talent pipeline. This points to preparedness as the space broadens from process mining into process intelligence and AI-enabled workflows.

Strategic Partnerships: A new alliance with a major data and AI platform provider expands product integrations and go-to-market reach into enterprise AI workflows. Such ecosystem momentum supports broader adoption and commercial expansion.

Investor Backing & Capital Strength: Fresh equity and debt in 2026—a $65M Series C in March and a $35M facility in July—provide resources to scale product and go-to-market, with management noting total 2026 funding surpassed $100M. These financings are corroborated by company disclosures and press coverage.

Market Expansion: Company communications describe expansion into hundreds of communities across multiple states, with named operators such as Navion and Novellus moving from pilots to broader rollouts. These signals point to cohort expansion rather than isolated deployments.

Strategic Partnerships: Live integrations with ALIS, ECP, and Yardi—plus PointClickCare and August Health slated in 2026—are positioned to extend reach across a large share of senior‑living workflows. The company frames these connections as enablers of nationwide deployment and day‑to‑day interoperability.

Strong Revenue Growth: Revenue expanded rapidly, with FY2025 up 83% to about $1.27B and Q1/Q2 2026 up 36% and 22% year over year, respectively. Management also raised 2026 revenue guidance to approximately $1.595–$1.605B.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with Diagnostics up 34.7% in Q1 and 20% in Q2 2026 and Insights/data licensing up 36% in Q2 alongside about $200M in new licenses. Rising oncology test volumes (28–31% YoY) and accelerating MRD tests (~4,700 in Q4 2025 to ~9,000 in Q2 2026) reinforce multiple growth engines.

Profitability: The company achieved its first GAAP-profitable quarter in Q2 2026 (net income about $5.6M; Adjusted EBITDA ~$8.0M). Guidance points to further improvement in 2026, indicating progress toward sustained profitability.

Investor Backing & Capital Strength: A $70M Series C announced on May 28, 2025 and the April 30, 2025 acquisition of Hashboard signal substantial resources and scale-up momentum. These moves indicate ample runway to fund product development and go-to-market execution.

Strategic Partnerships: Recognition at Snowflake Summit 2026 as Product Partner of the Year for Agentic Analytics and deep Snowflake integrations point to strong ecosystem alignment. This partner-led motion can accelerate adoption within a key data cloud.

Product Line Growth: Since late 2024 the company has shipped new capabilities (e.g., Explore drag-and-drop analytics; enhanced AI/agent features like Agent Observability) and expanded into BI via the Hashboard acquisition. A visible 2025–2026 release cadence suggests active investment and a broader user footprint.

Strong Revenue Growth: Revenue is accelerating with multiple raised full‑year outlooks and consecutive quarters of rapid top‑line increases. The business also highlights a long “beat and raise” cadence into 2026.

Profitability: GAAP net income turned positive in 2026 alongside expanding adjusted EBITDA. Management continues to guide to improved margins through the year.

Healthy Cash Flow: Free cash flow is rising and full‑year cash generation guidance was increased. Disclosures point to stronger operating cash flow through the first half of 2026.

Strong Market Position & Advantage: Independent analysts continue to place Qualtrics at the front of its market, with Gartner naming it a Leader in the Magic Quadrant for Voice of the Customer Platforms and positioning it highest on Ability to Execute and furthest on Completeness of Vision. This standing typically aligns with robust enterprise demand and supports commercial momentum.

Market Expansion: The company closed a $6.75 billion acquisition of Press Ganey Forsta on May 18, 2026, materially expanding its healthcare experience footprint and enlarging its data assets. Such scope increases are noted as common precursors to revenue growth and broader vertical penetration.

Innovation-Driven Growth: Qualtrics highlights rapidly expanding AI capabilities and analysis of billions of interactions annually, with usage of AI features surging and adoption widespread among large enterprise accounts. This product momentum supports upsell and cross‑sell into the installed base.

Innovation-Driven Growth: Product launches such as AI Search Lift and ongoing rollouts of Brand Lift, Outcomes Lift, and cookieless measurement point to active R&D and continued expansion of capabilities.

Strategic Partnerships: Recent agreements with partners like DAX US for audio measurement and selections by large media owners (e.g., Comcast Advertising, Vevo, Warner Bros. Discovery) signal expanding distribution and commercial traction.

Future-Ready Strategy: Positioning around cross-platform, cookieless, and AI-aware measurement, alongside regular industry research and benchmarks, indicates alignment with post-cookie and AI-era advertiser needs.

Market Expansion: PSA announced two new U.S. grading hubs (Plano, TX and Boca Raton, FL) and its first full‑scale European facility in Frankfurt targeted for summer 2026. Feedback suggests these moves are aimed at increasing throughput and serving growing international demand.

Strategic Partnerships: In May 2024, Collectors and eBay completed transactions to integrate vaulting, grading, and selling—PSA acquired the eBay Vault and the firms entered a commercial agreement. Feedback suggests this creates a more end‑to‑end hobby stack that can drive submissions and liquidity.

Investor Backing & Capital Strength: Sports Business Journal reported a planned $200M investment to expand operations and hire around 1,000 roles through 2026, alongside earlier financing of $100M at a multibillion valuation. These commitments indicate ample capital to scale facilities, technology, and headcount.

Strong Revenue Growth: Recent results show revenue up 9.6% year over year in Q2 2026 (6.8% organic; 8.2% excluding product sunsets), with 2025 up 7.5% and year‑to‑date 2026 up 10.2% on a reported basis. Growth is led by Morningstar Credit and core data/software platforms such as Morningstar Direct and PitchBook.

Profitability: Operating and adjusted operating margins expanded in Q2 2026 alongside a 29% rise in adjusted diluted EPS to $3.10, and 2025 saw increases in operating income and adjusted operating income. These gains were supported by stronger contribution from Credit and the accretive effect of the CRSP acquisition.

Healthy Cash Flow: Free cash flow and operating cash flow increased sharply in Q2 2026, with free cash flow nearly doubling year over year. This improved cash generation coincided with active buybacks and dividends.

Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.

Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.

Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.

Investor Backing & Capital Strength: Multiple funding rounds totaling around $100M, including a $52.5M Series B at a reported $400M valuation, indicate strong investor support and runway to scale. These resources are repeatedly linked to hiring, product development, and go‑to‑market execution.

Market Expansion: General availability in June 2024 and the launch of a dedicated EU region in 2025 signal commercial maturity and geographic reach. Continued integrations and partner-led launches further reflect expansion beyond the initial user base.

Strategic Partnerships: Formal alignment with DuckDB Labs and 50+ integrations (e.g., Tableau, Power BI, Fivetran, Monte Carlo) suggest a growing ecosystem that amplifies distribution and adoption. Named launch partners in Europe reinforce go‑to‑market momentum.